A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical trial is to investigate the safety and efficacy of Papillex® on the regression of abnormal cervical cells caused by HPV in women with a cervical intraepithelial neoplasia (CIN) 1 or 2 diagnosis. The main question it aims to answer is: Is there a difference in the proportion of participants with a regression in CIN based on histology or cytology from baseline at day 180 between Papillex® and placebo? Participants will be asked to consume Papillex® or placebo for 180 days, complete questionnaires, a PAP smear, HPV test, and colonoscopy (where applicable).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta w wieku 25-55 lat
- •Nie może być w ciąży; kobiety w wieku rozrodczym muszą mieć negatywny test ciąży i stosować zatwierdzoną metodę antykoncepcji przez cały czas trwania badania
- •Potwierdzona diagnoza CIN1+ (zmian nieprawidłowych w szyjce macicy) oraz dodatni test na wirusa HPV przy poprzedniej wizycie i aktualnie
- •Chęć dostarczenia kopii wyników badań histologicznych lub cytologicznych
- •Zgoda na utrzymywanie dotychczasowych nawyków (dieta, aktywność fizyczna, leki, suplementy, sen) przez czas badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 25 Years
- Maximum age
- 55 Years
- Last updated (source)
- July 8, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
KGK Science Inc.
London, Canada
Trial contact
Erin Lewis, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.